A recent study indicates that the Covishield vaccine remained effective against moderate-to-severe COVID-19 even as India faced a deadly second wave, spurred by the Delta variant. The Serum Institute manufacted jab is one of three vaccines that have been used to administer more than 1.2 billion jabs to India’s adult population.
Further details awaited.
